Remove medical-affairs-uptick
article thumbnail

Medical Affairs Uptick

PharmExec

Experts in attendance at Pharma 2022 share insights on medical affairs.

Medical 52
article thumbnail

Our predictions for Pharma in 2023

Impetus Digital

Medical Affairs evolving and embracing digital transformation. Medical Affairs will continue evolving. A recent McKinsey & Company report titled A vision for Medical Affairs in 2025 provides fantastic insights into the evolution of Medical Affairs.

Pharma 109
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Healthcare Watch July/August 2022

PM360

Medical Affairs, Eli Lilly, told FiercePharma. While pharma has seen a serious uptick in recent migraine treatment and services, this type of stigma can be an obstacle in patients’ treatment and well-being. Spectral Medical Inc. FDA Update. Drug Approvals. Med Device Approvals.

article thumbnail

The traditional pharmaceutical commercialization model is outdated

Clarify Health

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. Despite this uptick, revenue per drug has declined. Take Zolgensma, for example.